APA citiranje

Gullà, A., Hideshima, T., Bianchi, G., Fulciniti, M., Samur, M. K., Qi, J., . . . Anderson, K. C. (2017). Protein Arginine Methyltransferase 5 (PRMT5) has prognostic relevance and is a druggable target in Multiple Myeloma. Leukemia.

Citação norma Chicago

Gullà, Annamaria, et al. "Protein Arginine Methyltransferase 5 (PRMT5) Has Prognostic Relevance and Is a Druggable Target in Multiple Myeloma." Leukemia 2017.

MLA citiranje

Gullà, Annamaria, et al. "Protein Arginine Methyltransferase 5 (PRMT5) Has Prognostic Relevance and Is a Druggable Target in Multiple Myeloma." Leukemia 2017.